Nelociguat
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2007 (NCT00565565)
Timeline
Indications
Mechanism of action
NPR1 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- bay 60-4552
- bay-60-4552
- bay60-4552
- bay60-4552
- bay60-4552
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01168817 | Phase 2 | Aug 1, 2010 | Bayer |
| NCT01110590 | Phase 1 | Jan 1, 2010 | Bayer |
| NCT00565565 | Phase 1 | Oct 1, 2007 | Bayer |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bayer | For profit | 3 | 3 | 2 | 2007 |
1 organizations
Page 1 / 1